Table 2:
Percentage of PWDH HIV who were VLS, year-end 2035.
| Scenario | R/E | Baseline: No CAB/RPV | 10% CAB/RPV* | 30% CAB/RPV* | 50% CAB/RPV* | 70% CAB/RPV* | 90% CAB/RPV* |
|---|---|---|---|---|---|---|---|
| Conservative † | All | 69.0% | 69.5% (0.5%) | 70.0% (1.0%) | 71.0% (2.0%) | 72.0% (3.0%) | 73.0% (4.0%) |
| Optimistic † | All | 69.0% | 70.0% (1.0%) | 71.5% (2.5%) | 73.5% (4.5%) | 75.5% (6.7%) | 78.0% (9.0%) |
| Conservative † | B/AA | 64.0% | 64.5% (0.5%) | 65.5% (1.5%) | 66.5% (2.5%) | 67.5% (3.5%) | 68.5% (4.5%) |
| Optimistic † | B/AA | 64.0% | 65.0% (1.0%) | 67.0% (3.0%) | 69.0% (5.0%) | 71.5% (7.5%) | 74.0% (10.0%) |
| Conservative † | H/L | 68.0% | 68.5% (0.5%) | 69.5% (1.5%) | 70.0% (2.0%) | 71.0% (3.0%) | 72.0% (4.0%) |
| Optimistic † | H/L | 68.0% | 69.0% (1.0%) | 71.0% (3.0%) | 72.5% (4.5%) | 74.5% (6.5%) | 77.0% (9.0%) |
| Conservative † | O | 75.5% | 76.0% (0.5%) | 76.5% (1.0%) | 77.0% (1.5%) | 78.0% (2.5%) | 79.0% (3.5%) |
| Optimistic † | O | 75.5% | 76.0% (0.5%) | 78.0% (2.5%) | 79.5% (4.0%) | 81.0% (5.5%) | 83.0% (7.5%) |
Numbers in parentheses are the absolute difference in percentage compared to the baseline scenario.
ART = antiretroviral therapy, B/AA = Black/African-American, CAB/RPV = Cabotegravir-rilpivirine, H/L = Hispanic/Latino, O = other racial/ethnic groups besides B/AA and H/L, PWDH = people with diagnosed HIV, VLS = viral load suppression.
*
The percentage refers to the percentage of PWDH with VLS assumed to be on CAB/RPV
†
The conservative scenario refers to the scenario in which CAB/RPV increases the length of VLS upon cessation of use; the optimistic scenario refers to the scenario in which CAB/RPV is assumed to also improve overall ART adherence.